A vaccine with the consensus FAPα mRNA encapsulated in a lipid nanoparticle (cFAP mRNA-LNP) prevented disease onset and arthritis development in a mouse model of RA [58]. This evidence concerns the gene FAP and rheumatoid arthritis.